Peer Review History
| Original SubmissionFebruary 22, 2025 |
|---|
|
PONE-D-25-09713SHORT TANDEM REPEAT VARIANTS ARE ASSOCIATED WITH RNA SECONDARY STRUCTURE AND GENE EXPRESSIONPLOS ONE Dear Dr. Kinney, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 01 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Karthikeyan Thiyagarajan, PhD Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please update your submission to use the PLOS LaTeX template. The template and more information on our requirements for LaTeX submissions can be found at http://journals.plos.org/plosone/s/latex . Additional Editor Comments: Dear Dr. Kinney, I appreciate your work concerning the association of short tandem repeats in RNA folding and gene expression, specifically referring to the context of genetic disorders. However, there are already several studies available concerning the concept of tandem repeat-associated diseases; please check these specific articles: https://pmc.ncbi.nlm.nih.gov/articles/PMC3960014/ and https://pubmed.ncbi.nlm.nih.gov/16254211/. How is your study different from those that exist already? It is also better to discuss from a thermodynamic point of view about the fold change due to variations of STRs. Also, the intervening STRs in terminal inverted repeats and palindromes may be crucial to affect their hairpin loop kind of structure formation associated with miRNA and transposable elements. Further, you could consider the role of methylation-related specific genes, discussing the methylation and demethylation processes during the suppression and expression of the genes. Besides, I have some additional comments and suggestions: Have you predicted Z-DNA and H-DNA caused by short tandem repeats with your study? Because I didn't see more detail in the result and discussion. Hydrophilic amino acids are perhaps more tolerated due to the expansion of specific STR stretches, according to Katti et al., 2001, as you have cited, so please verify whether over-represented? Figure 1B is not clear about the cluster assignments without providing any cluster combination grouping names, from a genetic point of view, the STR-induced variations of the cluster perhaps representing alternative alleles. Please explain better and make Figure 2B self-explanatory. You could represent AA, AB, BB like this or using any specific conventions. Have you compared the normal STR besides the fSTR with expanded stretches to the wild ones (normal STR) that affect gene expression? For instance, a similar concept in plants was explained before in plants; please see this article: https://www.nature.com/articles/ng822z#:~:text= This%20indicates%20that%2C%20in%20these,DNA%20than%20in%20repetitive%20DNA. As you have mentioned, "fSTRs by unit are harder to interpret" because, in real time, the expression of the genes depends on many factors; however, the specific expansion of SSR due to polymerase slippage-derived errors, etc., may have a role in altered expression in exceptional cases with genetic diseases, etc. But in general, if you see even the SSR motifs from specific geographical isolates, perhaps they are more conserved than others. So, the study with fSTR with differential gene expression is perhaps more applicable to the specific individuals than others; in this case, you may need to interpret your results from Figure 3 carefully, as there are contradicting points about the accessibility. Even if you speculate about poly AT and poly TA pairing, the folding and unfolding need specific temperature-dependent variations with specific examples, like fSTR information comparing the housekeeping genes from humans to apes, etc. Figure 4: Is this figure derived from the similarity correlation score for the tallied pairs of fSTR alleles? You have shown the associations of different fSTR between shorter and longer variants. Is it with a CAG fSTR that more associations with gene expression occur? And how would you infer the effect due to the stability of the folding between the shorter and longer variants? You have discussed more about the accessibility, but why didn't you consider the stability of RNA structure due to the variations of motifs as you have compared through the bpRNA-align? You have also mentioned the use of the RNAfold program to predict thermodynamic ensembles. Why didn't you show the relevancy of the structural change with a thermodynamic point of view for specific sequences that are varying for specific fSTRs? Large tandem repeats are also known to be associated with diseases. How do you compare them with STRs, and which major genes were focused on for differential gene expression through DESeq2? I suggest you revise your manuscript as suggested by me and reviewers, make the contents more succinct, please try to avoid speculations, and please make the figures as self-explanatory. I also suggest comparing the species from other kingdoms; even you could compare specific housekeeping genes forms from prokaryotes to see whether there are any folding and gene expression differences due to orthologous gene comparisons, and you can also compare the specific duplicated or paralogous variations within a specific species or even with the specific genes from humans. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: N/A Reviewer #3: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: statistical analysis maybe has not been performed appropriately and rigorously, for example following: Figure 3 – Effects of fSTR variants on RNA accessibility. Accessibility is inferred from the tally of unpaired bases using ViennaRNA. Results of three types are obtained: (a) accessibility increases with allele length; (b) accessibility decreases with allele length; and (c) accessibility is not associated with allele length. (d) reverse complementary sequences tend decrease RNA accessibility. Reviewer #2: Thank you for the opportunity to review the manuscript: "Short tandem repeat variants are associated with RNA secondary structure and gene expression". The manuscript presents a comprehensive analysis of the impact of short tandem repeat (STR) variants on RNA folding and gene expression. The study leverages data from the 1000 Genomes Project and ViennaRNA to identify transcribed STRs that affect RNA secondary structure, providing valuable insights into the role of STRs in gene regulation. The strengths of the manuscript include its robust computational approach, the large dataset used for analysis, and the novel findings regarding the association between STR variants and RNA accessibility. However, the manuscript could benefit from a more detailed discussion on the biological implications of the findings and potential experimental validation to support the computational predictions. Additionally, the characterization of STRs by motif length and gene level annotation, while thorough, could be expanded to include more diverse genomic contexts. Overall, the study makes a significant contribution to the understanding of STRs and their effects on RNA structure and gene expression, paving the way for future research in this area. Major issues: 1. What parameters were used to identify STR variants in 2,529 samples from the 1000 genomes project? I cannot find this information in the MS. Please specify the methods and tools used for STR variant identification. Additionally, describe in detail the lengths and variations of the tandem repeats considered as STRs in this study. 2. There was any association with STRs of different repeat length? 3. Please provide all raw data including the coordinates of tested genes and STRs. 4. Would it be possible for G-quadruplexes to form in G-rich STRs? 5. Is the representation of STRs different in gene regions compared to non-gene regions? Please provide statistics on the occurrence of individual STRs. 6. The study relies heavily on computational predictions, and the lack of experimental validation is a notable weakness. Incorporating experimental data to support the computational findings would strengthen the overall conclusions and provide additional credibility to the results. If not provide, please suggest experimental design of verification in the discussion. Reviewer #3: This manuscript presents a compelling and timely investigation into the role of short tandem repeat (STR) variants in influencing RNA secondary structure and their potential downstream effects on gene expression. The authors integrate data from the 1000 Genomes Project with RNA structure predictions using ViennaRNA, and associate RNA structural alterations with expression profiles from Geuvadis RNA-seq data. The identification of 17,446 fSTRs, including 356 with significant expression associations, contributes meaningfully to our understanding of regulatory variation beyond SNPs. Major Comments: 1. Experimental Validation: While the computational predictions are strong, the manuscript would benefit from even a brief discussion of possible experimental strategies to validate the RNA structure changes, such as SHAPE-seq or DMS-seq. 2. Functional Implications: The discussion could be expanded to address how fSTR-induced RNA structural changes might mechanistically influence RNA processing, stability, or translation beyond splicing—particularly for those fSTRs located in UTRs or coding regions. 3. Statistical Considerations: It would be helpful if the authors described any multiple testing corrections applied during the association analysis between cluster assignments and gene expression. A false discovery rate threshold would bolster confidence in the reported 356 significant fSTRs. 4. Visualization: The figures could be improved with clearer legends and annotations, particularly for readers who may not be familiar with RNA structural clustering or exemplars. Minor Points: 1. The manuscript would benefit from language editing in several places to improve clarity and flow, particularly in the abstract and introduction. 2. Please ensure all acronyms (e.g., fSTR, bpRNA) are defined at first use in the main text. 3. Some references for gene expression may be helpful. a. Inhibitory Effect of Multimodal Nanoassemblies against Glycative and Oxidative Stress in Cancer and Glycation Animal Models. BioMed Research International. 2021 Apr 9;2021:8892156. b. Revisiting global gene expression analysis. Cell. 2012 Oct 26;151(3):476-82. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-25-09713R1SHORT TANDEM REPEAT VARIANTS ARE ASSOCIATED WITH RNA SECONDARY STRUCTURE AND GENE EXPRESSIONPLOS ONE Dear Dr. Kinney, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 11 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Karthikeyan Thiyagarajan, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Dear Authors, Most of your revisions and responses are acceptable. The manuscript is directly based on the computational prediction of short tandem repeat-based RNA folding and its impact on gene expression, etc. So, there is no experimental proof; however, you have added relevant experiment articles to support your analysis and hypothesis. I suggest please changing the title to "SHORT TANDEM REPEAT VARIANTS ARE POSSIBLY ASSOCIATED WITH RNA SECONDARY STRUCTURE AND GENE EXPRESSION". So it is understandable about the specific RNA folding due to tandem repeat variation for the possible associations with gene expressions with a prediction basis rather than the wet lab-related experimental approaches. Wherever required, please change throughout the manuscript to emphasize your results about the possibility of the associations with gene expressions rather than completely concluding the associations with the expression that may need additional lab experiments. One of the reviewers also suggested raw data with the coordinates of the genes tested and STRs, but your response was, "We look forward to it!" Please clarify. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: All comments have been adequately addressed, I believe the results are meaningful. The authors tried to explain in detail. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
SHORT TANDEM REPEAT VARIANTS ARE POSSIBLY ASSOCIATED WITH RNA SECONDARY STRUCTURE AND GENE EXPRESSION PONE-D-25-09713R2 Dear Dr. Kinney, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Karthikeyan Thiyagarajan, PhD Academic Editor PLOS ONE Additional Editor Comments: Dear Authors, After careful scientific evaluations with peer reviews, I am pleased to confirm the manuscript entitled "SHORT TANDEM REPEAT VARIANTS ARE POSSIBLY ASSOCIATED WITH RNA SECONDARY STRUCTURE AND GENE EXPRESSION." has been accepted for publication in PLOS ONE. Kind regards, Karthikeyan Thiyagarajan PhD Academic Editor, PLOS ONE. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-09713R2 PLOS ONE Dear Dr. Kinney, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Karthikeyan Thiyagarajan Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .